A D–π–A featured type-I photosensitizer with NIR-II fluorescence emission for imaging-guided synergistic PDT and PTT cancer therapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Photoacoustic and Ultrasonic Imaging
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (84)
Show source-provided references
1. American cancer society nutrition and physical activity guideline for cancer survivors10.3322/caac.21719 ↗
2. Cancer statistics, 202310.3322/caac.21763 ↗
3. Trends in the approval of cancer therapies by the FDA in the twenty-first century10.1038/s41573-023-00723-4 ↗
4. Artificial intelligence-based multi-omics analysis fuels cancer precision medicine10.1016/j.semcancer.2022.12.009 ↗
5. Lobar or sublobar resection for peripheral stage IA non-small-cell lung cancer10.1056/NEJMoa2212083 ↗
6. Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics10.1016/j.gendis.2022.02.007 ↗
7. Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer10.1056/NEJMoa2214122 ↗
8. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance
9. The evolving tumor microenvironment from cancer initiation to metastatic outgrowth10.1016/j.ccell.2023.02.016 ↗
10. Metastasis10.1016/j.cell.2023.03.003 ↗
11. Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy10.1016/j.ccell.2023.02.014 ↗
12. New frontiers in immune checkpoint B7-H3 (CD276) research and drug development10.1186/s12943-023-01751-9 ↗
13. Functionalized liposomes for targeted breast cancer drug delivery
14. Angiogenic signaling pathways and anti-angiogenic therapy for cancer
15. Photodynamic and photothermal therapies: synergy opportunities for nanomedicine10.1021/acsnano.3c00891 ↗
16. A dual-locked activatable phototheranostic probe for biomarker-regulated photodynamic and photothermal cancer therapy10.1002/anie.202202966 ↗
17. Prostate-specific membrane antigen-targeted NIR phototheranostics for prostate
18. Diketopyrrolopyrrole-derived organic small molecular dyes for tumor phototheranostics10.1016/j.cclet.2021.10.054 ↗
19. Nanomaterials for photothermal and photodynamic cancer therapy10.1063/5.0047672 ↗
20. Combined photodynamic and photothermal therapy and immunotherapy for cancer treatment: a review10.2147/IJN.S388996 ↗
21. Nanotherapeutic intervention in photodynamic therapy for cancer10.1021/acsomega.2c05852 ↗
22. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
23. Near-infrared photodynamic and photothermal co-therapy based on organic small molecular dyes10.1186/s12951-023-02111-x ↗
24. Recent advances and prospects in organic molecule-based phototheranostic agents for enhanced cancer phototherapy10.1016/j.ccr.2023.215560 ↗
25. From low to no O2-Dependent hypoxia photodynamic therapy (hPDT): a new perspective10.1021/acs.accounts.2c00531 ↗
26. Gold nanoparticles-based photothermal therapy for breast cancer10.1016/j.pdpdt.2023.103312 ↗
27. Recent advances and clinical potential of near infrared photothermal conversion materials for photothermal hepatocellular carcinoma therapy10.1002/adfm.202301138 ↗
28. Design and preparation of organic small molecules in NIR-II and their application in fluorescence imaging/photothermal therapy/photoacoustic imaging10.1016/j.dyepig.2022.111010 ↗
29. Pathological mechanism of photodynamic therapy and photothermal therapy based on nanoparticles10.2147/IJN.S269321 ↗
30. Functionalized nanomaterials for inhibiting ATP-dependent heat shock proteins in cancer photothermal/photodynamic therapy and combination therapy10.3390/nano14010112 ↗
31. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications10.1379/CSC-99r.1 ↗
32. Heat shock proteins in cancer: chaperones of tumorigenesis10.1016/j.tibs.2006.01.006 ↗
33. Type I photodynamic therapy by organic-inorganic hybrid materials: from strategies to applications10.1016/j.ccr.2019.05.016 ↗
34. Reactive oxygen species in photodynamic therapy: mechanisms of their generation and potentiation10.1016/bs.adioch.2017.03.002 ↗
35. A renal clearable nano-assembly with förster resonance energy transfer amplified superoxide radical and heat generation to overcome hypoxia resistance in phototherapeutics10.1002/anie.202411514 ↗
36. Self-assembled phthalocyanine-based nano-photosensitizers in photodynamic therapy for hypoxic tumors10.1039/D4QM00602J ↗
37. Synergy of hypoxia relief and heat shock protein inhibition for phototherapy enhancement10.1186/s12951-020-00758-4 ↗
38. Assembly of multifunction dyes and heat shock protein 90 inhibitor coupled to bovine serum albumin in nanoparticles for multimodal photodynamic/photothermal/chemo-therapy10.1016/j.jcis.2021.01.052 ↗
39. Acceptor planarization and donor rotation: a facile strategy for realizing synergistic cancer phototherapy via type I PDT and PTT10.1021/acsnano.1c10019 ↗
40. A self-assembly-induced exciton delocalization strategy for converting a perylene diimide derivative from a Type-II to Type-I photosensitizer10.1002/smll.202307414 ↗
41. Efficient NIR-II Type-I AIE photosensitizer for mitochondria-targeted photodynamic therapy through synergistic apoptosis-ferroptosis10.1021/acsnano.2c12319 ↗
42. Recent advances in near-infrared-II hollow nanoplatforms for photothermal-based cancer treatment10.1186/s40824-022-00308-z ↗
43. NIR-II aggregation-induced emission luminogens for tumor phototheranostics
44. Time-resolved fluorescence imaging in biology and medicine10.1088/0022-3727/35/9/201 ↗
45. Fluorescence optical imaging in anticancer drug delivery10.1016/j.jconrel.2016.02.022 ↗
46. Revisiting the classification of NIR-absorbing/emitting nanomaterials for in vivo bioapplications10.1038/am.2016.106 ↗
47. Exploiting the biological windows: current perspectives on fluorescent bioprobes emitting above 1000 nm10.1039/C5NH00073D ↗
48. Design of NIR-II high performance organic small molecule fluorescent probes and summary of their biomedical applications10.1016/j.ccr.2022.214609 ↗
49. Second near-infrared window fluorescence nanoprobes for deep-tissue in vivo multiplexed bioimaging10.1016/j.addr.2023.114697 ↗
50. Near-infrared fluorescence probes for surgical navigation10.1016/j.mtchem.2018.07.005 ↗
51. Albumin-mediated molecular competition of supramolecular photosensitizers for NIR-II imaging-guided phototherapy10.1016/j.dyepig.2024.112191 ↗
52. Brightness strategies toward NIR-II emissive conjugated materials: molecular design, application, and
53. Anionic heptamethine cyanine as reactive sulfur species-activated probe: application of NIR-II fluorescence imaging for in vivo visualization of glutathione10.1016/j.snb.2025.137371 ↗
54. In vivo NIR-II fluorescence imaging for biology and medicine10.1038/s41566-024-01391-5 ↗
55. Orchestrated strategies for developing fluorophores for NIR-II imaging10.1002/adhm.202300537 ↗
56. Biomedical applications of NIR-II organic small molecule fluorescent probes in different organs10.1016/j.ccr.2024.216122 ↗
57. Bright asymmetric shielding strategy-based NIR-II probes for angiography and localized photothermal therapy
58. A novel AIE-NIR-II nano-contrast agent for monitoring and evaluating kidney transplant
59. Regulating the photophysical property of organic/polymer optical agents for promoted cancer phototheranostics10.1002/adma.201806331 ↗
60. Design of superior phototheranostic agents guided by jablonski diagrams10.1039/D0CS00671H ↗
61. Enhancement approaches for photothermal conversion of donor-acceptor conjugated polymer for photothermal therapy: a review
62. Strategies to construct efficient singlet oxygen-generating photosensitizers10.1016/j.ccr.2022.214780 ↗
63. Reviewing the evolutive ACQ-to-AIE transformation of photosensitizers for phototheranostics10.1002/bio.4655 ↗
64. Aggregation-induced emission photosensitizer-based photodynamic therapy in cancer: from chemical to clinical10.1186/s12951-022-01553-z ↗
65. An NIR-II excitable AIE small molecule with multimodal phototheranostic features for orthotopic breast cancer treatment10.1002/adma.202309748 ↗
66. Molecular engineering to boost AIE-active free radical photogenerators and enable high-performance photodynamic therapy under hypoxia10.1002/adfm.202002057 ↗
67. Theranostic nanodots with aggregation-induced emission characteristic for targeted and image-guided photodynamic therapy of hepatocellular carcinoma10.7150/thno.29101 ↗
68. Emerging designs of aggregation-induced emission agents for enhanced phototherapy applications
69. Unveiling mechanism of organic photogenerator for hydroxyl radicals generation by molecular modulation10.1002/smll.202104857 ↗
70. Recent advances of AIE dots in NIR imaging and phototherapy10.1039/C9NR06012J ↗
71. Photothermal agents based on small organic fluorophores with intramolecular motion10.1016/j.actbio.2022.07.004 ↗
72. Recent advances in near-infrared-II organic J-aggregates for bio-applications10.1016/j.ccr.2024.216379 ↗
73. Synchronously boosting type-I photodynamic and photothermal efficacies via molecular manipulation for pancreatic cancer theranostics in the NIR-II window10.1016/j.biomaterials.2022.121476 ↗
74. Anti-quenching NIR-II J-Aggregates of benzo[c]thiophene fluorophore for highly efficient bioimaging and phototheranostics10.1002/adma.202211632 ↗
75. An all-round athlete on the track of phototheranostics: subtly regulating the balance between radiative and nonradiative decays for multimodal imaging-guided synergistic therapy10.1002/adma.202003210 ↗
76. Zwitterionic AIEgens: rational molecular design for NIR-II fluorescence imaging-guided synergistic phototherapy10.1002/adfm.202007026 ↗
77. De Novo Design of Reversibly pH-Switchable NIR-II Aggregation- Induced Emission Luminogens for Efficient Phototheranostics of Patient-Derived Tumor Xenografts10.1021/jacs.2c10076 ↗
78. Multiwfn: a multifunctional wavefunction analyzer10.1002/jcc.22885 ↗
79. Polymerization-enhanced photosensitization10.1016/j.chempr.2018.06.003 ↗
80. Rational design of pyrrole derivatives with aggregation-induced phosphorescence characteristics for time-resolved and two-photon luminescence imaging
81. An NIR-II two-photon excitable AIE photosensitizer for precise and efficient treatment of orthotopic small-size glioblastoma10.1002/adma.202413164 ↗
82. Rational design of a two-photon probe with solvatochromic emission and AIE-Activity for lipid droplet specific imaging10.1016/j.dyepig.2023.111735 ↗
83. An asymmetric NIR-II organic fluorophore with an ultra-large stokes shift for imaging-guided and targeted phototherapy10.1021/acsbiomaterials.4c00496 ↗
84. Boosting luminescence efficiency of Near-Infrared-II aggregation-induced emission luminogens via a Mash-Up strategy of π-Extension and deuteration for dual-model image-guided surgery10.1021/acsnano.3c11078 ↗